Tissue Engineered Collagen Biomaterials Market
Tissue Engineered Collagen Biomaterials Market (Source - Bovine, Porcine, Marine, and Chicken; Application - Orthopedic and Wound Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Press Release :
Tissue Engineered Collagen Biomaterials Market: Snapshot
Tissue engineered collagen biomaterials are widely used in plethora of applications. Dental, pharmacological, and medical are some of the key sectors to mention. These materials are uses in many purposes such as orthopedic and wound care. It also holds use as a carrier in drugs administration. By source, tissue engineered collagen biomaterials market can be segmented into porcine, bovine, chicken, marine, and others.
The growth of the global tissue engineered collagen biomaterials market is estimated to be fueled during forecast period by rising use of collagen in healthcare sector, specifically in regenerative medicine.
Increased Demand in Healthcare Sector Spurring Market Growth
Use of collagen as a substitute to bone is rising in recent years. This shift is triggering the tissue engineered collagen biomaterials market. Collagen has diverse properties. It helps in stimulating in tissue growth. It is also found to be useful as a relieving substance in various tissue and bone injuries. Growing inclination toward use of collagen in wound healing process is another major element stimulating the demand for these products. In recent time, there is tremendous rise in number of worldwide population with health issues such as low bone mass and osteoporosis. Rising demand for tissue engineered collagen biomaterials has stimulated the market growth. Besides, growing older population all across the world is expected to open new avenues for global tissue engineered collagen biomaterials market growth.
Growing Business Strategies by Players Widening Market Sphere
Major players in the global tissue engineered collagen biomaterials market are chasing diverse strategic moves such as mergers and acquisitions. Besides, they are heavily investing in research and development activities. The key motive of this move is to improve usability of collagen in diverse medical applications. All these moves are helping them to strengthen their position in the market.
Global Tissue Engineered Collagen Biomaterials Market: Snapshot
Mergers, acquisitions, and distribution agreements are some of the methods leveraged by success-hungry players in the global tissue engineered collagen biomaterials market in order to grow their shares. One of the prominent manufacturers Medtronic, for instance, acquired Covidien, a global healthcare products company, in January 2016 to gain greater stronghold in the global medical device industry.
The global tissue engineered collagen biomaterials market has been majorly fuelled by the extensive research and development activities in regenerative medicine and rising use of collagen as bone substitutes. Another growth driver in the market is the use of collagen in wound healing which offers numerous benefits in terms of stimulating tissue growth and ensuring relief for a variety of injuries on bones and tissues.
On the flipside, however, non-rigidity, potential for antigenicity through telopeptides and collagen materials have the potential to cause cell behavior alteration. This is serving to act as a deterrent to the global tissue engineered collagen biomaterials market. In addition, the transmission of lethal diseases such as mad-cow disease and bird flu, and growing number of government regulations for quality assurance of animal derived products are also negatively impacting the market.
A report by Transparency Market Research forecasts the global tissue engineered collagen biomaterial market to rise at a solid CAGR of 10.4% from 2017 to 2025 to become worth US$5.4 bn in 2025 from US$ 2.2 bn in 2016.
Wound Care Application Segment to Rise at Maximum Pace Owing to Rising Burn Injuries in U.S.
The global tissue engineered collagen biomaterial market can be segmented depending upon application into orthopedics and wound care, among others. The orthopedics segment, at present, leads with maximum market share due to the numerous applications in bone, tendon, and ligament injuries of collagen. As per a report by the National Osteoporosis Foundation in 2014, about 54 million people over 50 years of age in the U.S. are affected by low bone mass and osteoporosis and this has helped catalyze growth in the market.
The wound care segment trails the orthopedics segment in terms of market share and going forward, is expected to register a strong growth pace. According to the American Burn Association (ABA), about a million burn injuries occurs annually in the U.S. and nearly 4,500 patient succumb to it.
Burgeoning Geriatric Population Propels Growth in Asia Pacific Market
Geographically, North America is a market leader that is expected to retain its dominant position in the years ahead as well. A solid manufacturing infrastructure, increasing collagen applications across various industries, and growing thrust on research to develop unique solutions for tissue engineering leading to emergence of many collagen-based products, will likely boost growth in the market. The North America market is slated to become worth US$17 bn by 2025 by clocking a CAGR of 10.0%.
In terms of growth rate, however, Asia Pacific is anticipated to outshine all other regions by registering a solid CAGR of 11.1% from 2017 to 2025. A burgeoning geriatric population and the increasing instances of chronic diseases are said to be driving growth in the region. Growing uptake of advanced wound care products by healthcare professionals and favorable government reimbursement policies are also serving to bolster the tissue engineered collagen biomaterials market in Asia Pacific.
Some of the prominent participants operating in the global tissue engineered collagen biomaterials market are Collagen Matrix Inc., Medtronic, Advanced BioMatrix Inc., Kyeron B.V., Collagen Matrix, Collagen Solutions Plc., CollPlant Ltd., Fraunhofer-Gesellschaft, GENOSS Co., Ltd., and Maxigen Biotech Inc.
Global Tissue Engineered Collagen Biomaterials Market: Overview
This report provides in-depth region wise and country wise analysis of the tissue engineered collagen biomaterials market. Stakeholders of this report include manufacturers of tissue engineered collagen biomaterials, raw material suppliers, research institutes involve in the research of tissue engineered collagen and new players planning to enter the market.
The report provides qualitative and quantitative analysis of the global tissue engineered collagen biomaterials market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global tissue engineered collagen biomaterials market in major countries globally such as the U.S., Canada, Germany, Italy, France, United Kingdom, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the tissue engineered collagen biomaterials with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global tissue engineered collagen biomaterials market. These factors would aid the stakeholders in establishing a strong foothold in the global tissue engineered collagen biomaterials market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the tissue engineered collagen biomaterials market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Global Tissue Engineered Collagen Biomaterials Market: Segmentation
The tissue engineered collagen biomaterials market has been segmented as by source, by application and by geography. Based on source the market has been segmented into bovine, porcine, marine, chicken and others. Based on application the market has been segmented into orthopedic, wound care and others.
Geographically, the tissue engineered collagen biomaterials market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, Italy, France, U.K., Spain, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the tissue engineered collagen biomaterials market in various regions has been provided in this section.
This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.
Global Tissue Engineered Collagen Biomaterials Market: Competitive Analysis
The report provides a detailed outline/blueprint of the tissue engineered collagen biomaterials market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Advanced BioMatrix Inc., Collagen Matrix Inc., CollPlant Ltd., Collagen Matrix, Collagen Solutions Plc., Fraunhofer-Gesellschaft, GENOSS Co., Ltd., Kyeron B.V., Maxigen Biotech Inc., and Medtronic.